Viracta Therapeutics to Present at the 5th Annual Solebury Trout Private Company Showcase
SAN DIEGO, Oct. 14, 2019 /PRNewswire/ -- Viracta Therapeutics, Inc., a precision oncology company targeting virus-associated malignancies, announced today that Ivor Royston, MD, President and Chief Executive Officer of Viracta, will present a company overview at the 5th Annual Solebury Trout Private Company Showcase in New York, NY on Friday, October 18, 2019 at 11:00 am ET at the offices of Davis Polk & Wardwell, LLP (Davis Polk).
- SAN DIEGO, Oct. 14, 2019 /PRNewswire/ -- Viracta Therapeutics, Inc., a precision oncology company targeting virus-associated malignancies, announced today that Ivor Royston, MD, President and Chief Executive Officer of Viracta, will present a company overview at the 5th Annual Solebury Trout Private Company Showcase in New York, NY on Friday, October 18, 2019 at 11:00 am ET at the offices of Davis Polk & Wardwell, LLP (Davis Polk).
- The Private Company Showcase is hosted together by David Polk, BMO, Donnelly Financial Solutions (DFIN) and CFGI.
- Viracta is a precision oncology company targeting virus-associated malignancies.
- Viracta is pursuing application of this Kick and Kill approach in other EBV associated malignancies, such as nasopharyngeal carcinoma, and other virus-related cancers.